Pharma Capital
CompanyCurrent (p)Value (£)
GlaxoSmithKline (GSK) 1677.00 123,382,692
Shire (SHP) 4734.50 120,660,200
AstraZeneca (AZN) 4960.00 102,681,722
Hikma Pharmaceuticals (HIK) 2000.00 19,020,220
GW Pharmaceuticals (GWP) 735.00 17,046,576
Indivior (INDV) 318.00 5,712,806
Abcam (ABC) 821.00 4,569,686
BTG (BTG) 580.00 3,230,542
Vectura (VEC) 157.60 3,131,441
Clinigen Group (CLIN) 770.00 2,555,776
SkyePharma (SKP) 443.00 2,325,201
Dechra Pharmaceuticals (DPH) 1688.00 2,148,436
Hutchison China (HCM) 3185.00 887,628
Genus (GNS) 1733.00 735,243
Horizon Discovery Group (HZD) 162.50 420,592
Quantum Pharma (QP.) 40.50 400,950
Futura Medical (FUM) 49.75 339,642
Amryt Pharma (AMYT) 21.25 325,665
Sarossa (SARS) 1.52 213,131
OptiBiotix Health (OPTI) 80.00 210,021
Alliance Pharma (APH) 47.75 203,206
Circassia Pharmaceuticals (CIR) 106.00 189,817
Oxford Biomedica (OXB) 4.71 124,251
Allergy Therapeutics (AGY) 24.00 113,648
Anpario (ANP) 315.00 105,786
ECO Animal Health (EAH) 500.00 103,710
Arix Bioscience (ARIX) 192.50 102,497
Motif Bio (MTFB) 24.75 94,055
Bioventix (BVXP) 1812.50 90,444
Vernalis (VER) 25.13 55,697

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.